Delphinus Medical Announces Installation of SoftVue Breast Imaging System at UR Medicine
Delphinus Medical Technologies announced today the latest installation of its SoftVue™ 3D Whole Breast Ultrasound Tomography System since FDA approval of its advanced technology for screening women with dense breast tissue.
- Delphinus Medical Technologies announced today the latest installation of its SoftVue™ 3D Whole Breast Ultrasound Tomography System since FDA approval of its advanced technology for screening women with dense breast tissue.
- UR Medicine is now the third medical center in the world offering dense breast cancer screening with SoftVue.
- “SoftVue addresses the critical need for an effective, comfortable breast cancer screening solution for women with dense breasts.
- In addition, SoftVue is the only ultrasound-based breast imaging system that was approved by the FDA for same day screening as mammography for this population of women.